Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy [Phase 2]

View source ↗

Summary

Phase 2 study comparing epoetin alfa to placebo for treating anemia in AIDS patients on zidovudine has completed, assessing safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Acquired Immunodeficiency Syndrome, Anemia | Phase 2 | Status: COMPLETED